EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer
- 17 December 2018
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (6) , 1514-1522
Abstract
EphA3 is a member of Eph receptors, which is involved in tumorigenesis. The expression and clinical significance of EphA3 in colorectal cancer (CRC) have not been fully investigated.Keywords
Funding Information
- National Natural Science Foundation of China (81371611)
This publication has 27 references indexed in Scilit:
- Loss of EphA3 Protein Expression Is Associated With Advanced TNM Stage in Clear-Cell Renal Cell CarcinomaClinical Genitourinary Cancer, 2017
- EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathwaysCancer Letters, 2016
- Ephrin Receptor (Eph) -A1, -A2, -A4 and -A7 Expression in Mobile Tongue Squamous Cell Carcinoma: Associations with Clinicopathological Parameters and Patients SurvivalPathology and Oncology Research, 2013
- The EphA3 receptor is expressed in a subset of rhabdomyosarcoma cell lines and suppresses cell adhesion and migrationJournal of Cellular Biochemistry, 2008
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- Bidirectional Eph–ephrin signaling during axon guidanceTrends in Cell Biology, 2007
- Somatic mutations ofGUCY2F,EPHA3, andNTRK3 in human cancersHuman Mutation, 2006
- The role of ephrins and Eph receptors in cancerCytokine & Growth Factor Reviews, 2004
- Unified Nomenclature for Eph Family Receptors and Their Ligands, the EphrinsCell, 1997
- Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line.Journal of Biological Chemistry, 1992